Abstract
Vascular endothelial growth factor (VEGF) can promote angiogenesis but may also exert certain effects to alter the rate of atherosclerotic plaque development. To evaluate this potential impact on plaque progression, we treated cholesterol-fed mice doubly deficient in apolipoprotein E/apolipoprotein B100 with low doses of VEGF (2 μg/kg) or albumin. VEGF significantly increased macrophage levels in bone marrow and peripheral blood and increased plaque area 5-, 14- and 4-fold compared with controls at weeks 1, 2 and 3, respectively. Plaque macrophage and endothelial cell content also increased disproportionately over controls. In order to confirm that the VEGF-mediated plaque progression was not species-specific, the experiment was repeated in cholesterol-fed rabbits at the three-week timepoint, which showed comparable increases in plaque progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sueishi, K. et al. Atherosclerosis and angiogenesis. Its pathophysiological significance in human as well as in an animal model induced by the gene transfer of vascular endothelial growth factor. Ann. NY Acad. Sci. 811, 311–324 (1997).
Moulton, K.S. et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99, 1726–1732 (1999).
Asahara, T. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 965–967 (1997).
Asahara, T. et al. VEGF contributes to postnatal neovascularization by mobilizing bone-marrow derived endothelial progenitor cells. EMBO J. 18, 3964–3972 (1999).
Asahara, T. et al. Bone marrow of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation 85, 221–228 (1999).
Shi, Q. et al. Evidence for circulating bone marrow derived endothelial cells. Blood 92, 362–367 (1998).
Shen, H. et al. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81, 2767–2773 (1993).
Barleon, B. et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the receptor Flt-1. Blood 87, 3336–3343 (1996).
Clauss, M. et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cells and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172, 1535–1545 (1990).
Leek, R.D. et al. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J. Pathol. 190, 430–436 (2000).
Ross, R. et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 248, 1009–1012 (1990).
Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801–809 (1993).
Jonasson, L. et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131–138 (1986).
Polverini, P.J. et al. Activated macrophages induce vascular proliferation. Nature 269, 804–806 (1977).
Kaartinen, M., Penttila, A. & Kovanen, P.T. Mast cells accompany microvessels in human coronary atheromas. Atherosclerosis 123, 123–131 (1996).
Veniant, M.M. et al. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or Apolipoprotein B100. J. Clin. Invest. 100, 180–188 (1997).
Lopez, J.J. et al. VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc. Res. 40, 272–281 (1998).
Isner, J.M. & Asahara, T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest 103, 1231–1234 (2000).
Keck, P.J. et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309–1312 (1989).
Gown, A.M. et al. Human atherosclerosis: II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol. 125, 191–207 (1986).
Patterson, J.C. Capillary rupture with intimal hemorrhage as a causative factors in coronary thrombosis. Arch. Pathol. 25, 474–487 (1938).
Tenaglia, A.N. et al. Neovascularization in atherectomy specimens in patients with unstable angina. Am. Heart J. 135, 10–14 (1998).
Fernandez, P.B. et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65, 287–300 (2000).
Bhardway, R. & Sorg, C. Macrophages and angiogenesis. J. Leukoc. Biol. 57, 747–751 (1994).
Libby, P. et al. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am. J. Pathol. 124, 179–185 (1986).
Yonemitsu, Y. et al. Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (hemagglutinin virus of Japan) liposomes: an effective tool for the in vivo study of arterial diseases. Lab. Invest. 75, 313–323 (1996).
Lazarous, D.F. et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94, 1074–1082 (1996).
Brogi, E. et al. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. J. Clin. Invest. 92, 2408–2418 9 (1993).
Lagasse, E. & Weissman, I.L. Flow cytometric identification of murine neutrophils and monocytes. J. Imm. Meth. 197, 139–150 (1996).
Kolodgie, F.D. et al. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Arterioscler. Thromb. Vasc. Biol. 16, 1454–64 (1996).
Kratky, R.G., Ivey, J. & Rogers, K.A. The distribution of fibro-fatty atherosclerotic lesions in the aortae of casein-and cholesterol-fed rabbits. Atherosclerosis 1, 121–31 (1993).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Celletti, F., Waugh, J., Amabile, P. et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 7, 425–429 (2001). https://doi.org/10.1038/86490
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/86490
This article is cited by
-
Intramuscular injection of sotagliflozin promotes neovascularization in diabetic mice through enhancing skeletal muscle cells paracrine function
Acta Pharmacologica Sinica (2022)
-
Bone marrow-independent adventitial macrophage progenitor cells contribute to angiogenesis
Cell Death & Disease (2022)
-
Imaging angiogenesis in atherosclerosis in large arteries with 68Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease
EJNMMI Research (2021)
-
Expression of vascular infarction-related molecules after anti-vascular endothelium growth factor treatment for diabetic macular edema
Scientific Reports (2019)
-
Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine
Drug Delivery and Translational Research (2018)